Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

CLOVER HEALTH INVESTMENTS CO (CLOV)

191 + Investors. Track Smart Money conviction in CLOV. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -6
Streak
1Q ▼
Buyers last Q
51%

Smart Money Signals — CLOV

Based on 178 hedge funds · latest filing: 2025 Q4 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their CLOV positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🏔️

At the ownership peak (95% of max)

95% of all-time peak
178 hedge funds hold CLOV right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +5% more funds vs a year ago

fund count last 6Q
+9 new funds entered over the past year (+5% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction. The peak was reached in just 4 quarters from the low — a sharp move.
🟡

Slight buying edge — 51% buying

94 buying91 selling
Last quarter: 94 funds bought or added vs 91 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~31 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 52 → 49 → 29 → 31. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

52% of holders stayed for 2+ years

52% conviction (2yr+) 28% medium 20% new
93 out of 178 hedge funds have held CLOV for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -7%, value -28%

Value
-28%
Shares
-6%
Last quarter: funds added -7% more shares while total portfolio value only changed -28%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📊

Peak discovery — momentum slowing

37 → 52 → 49 → 29 → 31 new funds/Q
New funds entering each quarter: 52 → 49 → 29 → 31. CLOV is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Deep conviction — 67% of holders stayed 2+ years

67% veterans 10% 1-2yr 23% new
Of 191 current holders: 128 (67%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 54% AUM from top-100 funds

54% from top-100 AUM funds
32 of 178 holders are among the 100 largest funds by AUM, controlling 54% of total institutional value in CLOV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.3
out of 10
Low Exit Risk
Exit risk score 3.3/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CLOV

In 2025 Q4, 94 hedge funds were net buyers of CLOV (31 opened a new position, 63 added to an existing one), while 91 reduced or exited (54 trimmed, 37 sold completely) — a 51% buyer ratio, indicating a slight buying edge. 54% of total institutional value in CLOV is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -6 funds (more exits than new entries). Total institutional holders: 178.

Hedge Fund Ownership: CLOV

How many hedge funds hold CLOV — quarterly history vs. share price
Quarterly hedge fund ownership of CLOV vs. share price

Market Analysis: CLOV

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CLOV

Healthcare Healthcare Plans

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

38 top-rated funds 0 high-conviction
Consensus
6.9
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: CLOV
2026 Q1 Stats Unlock in 8 days 191 + Investors

Track Smart Money conviction in CLOV. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 191 200 -4.5%
13F Shares 135M 145M -6.77%
Total Value $316M $441M -28.38%
New Positions 31 29 +2
Increased Positions 87 80 +7
Closed Positions 39 29 +10
Reduced Positions 72 79 -7
Total Calls 10 10 -
Total Puts 5 6 -16.67%
PUT/CALL Ratio 0.5 0.6 Bullish

Statistics: CLOV

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

191 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CLOV. Verified SEC 13F-HR filings.

Top 25 institutional holders of CLOV — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Palacios Wealth Management, LLC 0.09% 51,624 $142K
2 SAGE RHINO CAPITAL LLC 0.07% 211,440 $372K
3 GSA CAPITAL PARTNERS LLP 0.05% 435,434
4 R Squared Ltd 0.04% 37,442 $66K
5 Turtle Creek Wealth Advisors, LLC 0.03% 220,000 $387K
6 Viewpoint Capital Management LLC 0.02% 30,000 $53K
7 marrick wealth, LLC 0.02% 15,000 $26K
8 Silverleafe Capital Partners, LLC 0.02% 40,000 $70K
9 USAdvisors Wealth Management, LLC 0.02% 35,000
10 Ketron Financial 0.01% 16,708 $29K
11 Alteri Wealth LLC 0.01% 18,275 $32K
12 SeaCrest Wealth Management, LLC 0.01% 41,100 $72K
13 Strategic Family Wealth Counselors, L.L.C. 0.01% 12,263 $22K
14 Farther Finance Advisors, LLC 0.00% 269,137 $458K
15 PNC FINANCIAL SERVICES GROUP, INC. 0.00% 3,764,034 $6.6M
16 CHESAPEAKE ASSET MANAGEMENT LLC 0.00% 2,400 $4K
17 Caitong International Asset Management Co., Ltd 0.00% 9,819 $17K
18 Performa Ltd (US), LLC 0.00% 8,000 $14K
19 SAPIENT CAPITAL LLC 0.00% 80,000 $141K
20 Pekin Hardy Strauss, Inc. 0.00% 10,500 $18K
21 Everhart Financial Group, Inc. 0.00% 12,546 $22K
22 INTECH INVESTMENT MANAGEMENT LLC 0.00% 107,686 $190K
23 Police & Firemen's Retirement System of New Jersey 0.00% 111,760 $197K
24 VANGUARD FIDUCIARY TRUST CO 0.00% 2,806,210 $4.9M
25 Arizona State Retirement System 0.00% 116,547 $205K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — CLOVER HEALTH INVESTMENTS CO (CLOV)

What does the Smart Money Trend signal show for CLOV?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their CLOV positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for CLOV?

Slight buying edge — 51% buying: Last quarter: 94 funds bought or added vs 91 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CLOV holders?

Elite ownership — 54% AUM from top-100 funds: 32 of 178 holders are among the 100 largest funds by AUM, controlling 54% of total institutional value in CLOV. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held CLOV?

52% of holders stayed for 2+ years: 93 out of 178 hedge funds have held CLOV for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.